Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Chicken pox vaccine OK for children with kidney disease

18.12.2002


Researchers at the Johns Hopkins Children’s Center report that two doses of the varicella vaccine for chicken pox given one to two months apart can be safe and effective in children with chronic kidney disease.



The findings, reported in the January issue of Pediatric Nephrology, are critical for chronic kidney disease patients, particularly children who will eventually undergo a kidney transplant. After transplantation, immunosuppressive medications put these children at high risk for severe chicken pox complications, including pneumonia, brain inflammation, and death.

"We recommend pediatric nephrologists include chicken pox vaccination as an important component of pre-end-stage renal disease and end-stage renal disease care," said the study’s lead author, Susan L. Furth, M.D, Ph.D., a pediatric nephrologist at the Children’s Center.


Varicella vaccine contains small doses of weakened strains of the chicken pox virus that activate immune system "memory" and mount a protective response to subsequent exposures.

In healthy children under 12 years of age, vaccination in a single dose is recommended, while two doses are recommended for adolescents. Without vaccination, infections in children whose immune systems have been weakened by a genetic disorder, disease, or medical treatment can cause serious complications.

In a multi-center, prospective, three-year clinical trial, Hopkins researchers, with the cooperation of the Southwest Pediatric Nephrology Study Group, identified 96 children with chronic kidney disease with no history of chicken pox. About half of these patients did not have detectable varicella antibodies. Each child received two injections of varicella vaccine, rather than the one dose typically given to healthy children. The doses were administered four to eight weeks apart.

One child developed chicken pox following a known exposure. There were no reported serious side effects following vaccination. Eleven patients developed a rash associated with the vaccine, and seven patients reported mild to moderate redness or soreness at the site of injection.

Over three years of follow-up, researchers report each child – including 16 children who received kidney transplants following vaccination – maintained the varicella antibody, and 87 percent retained antibody levels for more than three years. Although kidney transplant recipients tended to have lower varicella antibody levels during the first two years of follow-up, researchers report that antibody levels increased over time.


Children’s Center pediatric nephrologist Barbara A. Fivush, M.D., and researchers from the Johns Hopkins Bloomberg School of Public Health, Columbia Hospital at Medical City, and Merck & Co. contributed to the report. The study was funded by a grant from Merck & Co.

Jessica Collins | EurekAlert!
Further information:
http://www.hopkinsmedicine.org

More articles from Health and Medicine:

nachricht Diabetes mellitus: A risk factor for early colorectal cancer
27.05.2020 | Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg

nachricht Ultra-thin fibres designed to protect nerves after brain surgery
27.05.2020 | Martin-Luther-Universität Halle-Wittenberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Biotechnology: Triggered by light, a novel way to switch on an enzyme

In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".

Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...

Im Focus: New double-contrast technique picks up small tumors on MRI

Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.

researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...

Im Focus: I-call - When microimplants communicate with each other / Innovation driver digitization - "Smart Health“

Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.

When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...

Im Focus: When predictions of theoretical chemists become reality

Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.

Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...

Im Focus: Rolling into the deep

Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.

A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

International Coral Reef Symposium in Bremen Postponed by a Year

06.04.2020 | Event News

 
Latest News

German-British Research project for even more climate protection in the rail industry

28.05.2020 | Transportation and Logistics

A special elemental magic

28.05.2020 | Physics and Astronomy

Skoltech scientists get a sneak peek of a key process in battery 'life'

28.05.2020 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>